Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.35p
   
  • Change Today:
    -0.25p
  • 52 Week High: 11.85
  • 52 Week Low: 3.40
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 1,047,016
  • Market Cap: £23.20m

Deal with Barclays    Trade now with Barclays Stockbrokers

Dividends

Year End Type Amount Payment Date Ex-Div Date Record Date
  Final 00.00      
31-Dec-18 Interim 00.00      

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Historical interim dividends and record dates not previously collected

Note 3: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Eden Research Market Data

Currency UK Pounds
Share Price 4.35p
Change Today -0.25p
% Change -5.43 %
52 Week High 11.85
52 Week Low 3.40
Volume 1,047,016
Shares Issued 533.35m
Market Cap £23.20m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
16.74% below the market average16.74% below the market average16.74% below the market average16.74% below the market average16.74% below the market average
57.89% above the sector average57.89% above the sector average57.89% above the sector average57.89% above the sector average57.89% above the sector average
Income Not Available
Growth
5.04% above the market average5.04% above the market average5.04% above the market average5.04% above the market average5.04% above the market average
8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average

Eden Research Dividends

No dividends found

Trades for 24-Apr-2024

Time Volume / Share Price
14:28 10,000 @ 4.46p
13:30 140,000 @ 4.47p
13:11 40,000 @ 4.21p
11:47 279,960 @ 4.21p
11:46 280,675 @ 4.20p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page